[培美曲塞在晚期非小细胞肺癌二线治疗中的作用] - Suppr

Suppr

超能文献

[Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].

作者信息

Pérol M

机构信息

Service de Pneumologie-Phtisiologie, Hôpital de la Croix-Rousse, Lyon.

出版信息

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S14-7.

PMID:16273004

Abstract

摘要

相似文献

[Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S14-7.

Pemetrexed and maintenance therapy for non-small cell lung cancer.

Prescrire Int. 2011 Feb;20(113):39.

Pemetrexed in advanced non-small-cell lung cancer.

Expert Opin Pharmacother. 2010 Jun;11(8):1387-402. doi: 10.1517/14656566.2010.482560.

[Update of pemetrexed in thoracic oncology].

Bull Cancer. 2007;94 Spec No Actualites:S139-41.

Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.

Jpn J Clin Oncol. 2009 Jan;39(1):27-32. doi: 10.1093/jjco/hyn118. Epub 2008 Oct 24.

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

Lung Cancer. 2008 May;60(2):240-5. doi: 10.1016/j.lungcan.2007.10.008. Epub 2007 Nov 26.

Pemetrexed for the treatment of non-small-cell lung cancer.

Expert Rev Anticancer Ther. 2009 Sep;9(9):1195-209. doi: 10.1586/era.09.97.

The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial.

Expert Opin Pharmacother. 2010 Feb;11(2):321-4. doi: 10.1517/14656560903485672.

Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.

Prescrire Int. 2009 Jun;18(101):114.

[Study of use of pemetrexed in non-small cell lung cancer].

Farm Hosp. 2010 Jul-Aug;34(4):194-203. doi: 10.1016/j.farma.2009.12.010. Epub 2010 Jul 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S14-7.

Pemetrexed and maintenance therapy for non-small cell lung cancer.

Prescrire Int. 2011 Feb;20(113):39.

Pemetrexed in advanced non-small-cell lung cancer.

Expert Opin Pharmacother. 2010 Jun;11(8):1387-402. doi: 10.1517/14656566.2010.482560.

[Update of pemetrexed in thoracic oncology].

Bull Cancer. 2007;94 Spec No Actualites:S139-41.

Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.

Jpn J Clin Oncol. 2009 Jan;39(1):27-32. doi: 10.1093/jjco/hyn118. Epub 2008 Oct 24.

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

Lung Cancer. 2008 May;60(2):240-5. doi: 10.1016/j.lungcan.2007.10.008. Epub 2007 Nov 26.

Pemetrexed for the treatment of non-small-cell lung cancer.

Expert Rev Anticancer Ther. 2009 Sep;9(9):1195-209. doi: 10.1586/era.09.97.

The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial.

Expert Opin Pharmacother. 2010 Feb;11(2):321-4. doi: 10.1517/14656560903485672.

Prescrire Int. 2009 Jun;18(101):114.

[Study of use of pemetrexed in non-small cell lung cancer].

Farm Hosp. 2010 Jul-Aug;34(4):194-203. doi: 10.1016/j.farma.2009.12.010. Epub 2010 Jul 1.

[Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].

作者信息

Pérol M

机构信息

Service de Pneumologie-Phtisiologie, Hôpital de la Croix-Rousse, Lyon.

出版信息

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S14-7.

PMID:16273004

Abstract

摘要